Astrazeneca (AZN) Current Assets (2009 - 2026)
Astrazeneca's Current Assets came in at $27.97 billion for Q2 2026, down 3.4% from $28.94 billion a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca's Current Assets was $28.72 billion, up 11.2% from FY2024.
- Current Assets has increased in each of the last three years, with a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
- Going back by year, Current Assets was $25.83 billion in FY2024 (+3.1%), $25.05 billion in FY2023 (+10.9%), $22.59 billion in FY2022 (-13.9%) and $26.24 billion in FY2021 (+34.3%).
- The Q2 2026 figure represents the lowest quarterly Current Assets since Q1 2025.
- Year-over-year, Current Assets increased in seven of the last eight quarters, with growth averaging 9.0%.
- The fastest year-over-year change in Current Assets over five years came in Q3 2021 (growth of 46.9%), and the weakest in Q3 2022 (a decline of 24.2%).
- Business Quant data shows AZN's Current Assets at $29.61 billion (Q1 2026), $28.72 billion (Q4 2025) and $29.94 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn | 12.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.97 Bn |
| Mar 31, 2026 | 29.61 Bn |
| Dec 31, 2025 | 28.72 Bn |
| Sep 30, 2025 | 29.94 Bn |
| Jun 30, 2025 | 28.94 Bn |
| Mar 31, 2025 | 26.14 Bn |
| Dec 31, 2024 | 25.83 Bn |
| Sep 30, 2024 | 24.16 Bn |
| Jun 30, 2024 | 25.39 Bn |
| Mar 31, 2024 | 25.59 Bn |
| Dec 31, 2023 | 25.05 Bn |
| Sep 30, 2023 | 22.50 Bn |
| Jun 30, 2023 | 22.84 Bn |
| Mar 31, 2023 | 22.27 Bn |
| Dec 31, 2022 | 22.59 Bn |
| Sep 30, 2022 | 20.22 Bn |
| Jun 30, 2022 | 20.92 Bn |
| Mar 31, 2022 | 22.65 Bn |
| Dec 31, 2021 | 26.24 Bn |
| Sep 30, 2021 | 26.69 Bn |
API Access
Astrazeneca Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();